Advertisement
Advertisement
U.S. Markets open in 1 hr 28 mins
Advertisement
Advertisement
Advertisement
Advertisement

Kingfisher plc (KGFHY)

Other OTC - Other OTC Delayed Price. Currency in USD
5.76-0.19 (-3.19%)
At close: 03:53PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close5.95
Open5.86
BidN/A x N/A
AskN/A x N/A
Day's Range5.76 - 5.88
52 Week Range4.48 - 9.69
Volume320,828
Avg. Volume299,930
Market Cap5.978B
Beta (5Y Monthly)1.00
PE Ratio (TTM)7.46
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.30 (6.11%)
Ex-Dividend DateOct 06, 2022
1y Target EstN/A
  • CNW Group

    Liminal BioSciences to Report First Quarter 2022 Financial Results on May 10, 2022

    Liminal BioSciences Inc. (NASDAQ: LMNL) ("Liminal BioSciences" or the "Company"), today announced that it plans to report its first quarter 2022 financial results after market close on May 10, 2021. Liminal will host a conference call and webcast to discuss financial results at 8:30 am (ET) on Wednesday May 11, 2022.

  • CNW Group

    Liminal Biosciences to Present at Upcoming Investor Conferences

    Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biopharmaceutical company, announced that Bruce Pritchard, Chief Executive Officer at Liminal BioSciences is scheduled to present a company overview at the following upcoming investor conferences:

Advertisement
Advertisement